INVENTURUS KNOWLEDGE SOLUTIONS LIMITED — Earnings Release 2025

Jul 31, 2025

July 31, 2025

BSE Limited

The Listing Department Phiroze Jeejeebhoy Towers 25[th] Floor, Dalal Street Fort, Mumbai 400 001 Maharashtra, India BSE Scrip Code: 544309

National Stock Exchange of India Limited

The Listing Department Exchange Plaza, Plot No. C/1, G Block, Bandra Kurla Complex Bandra (East), Mumbai 400051 Maharashtra, India

NSE Symbol: IKS

Dear Sir/Ma’am,

Sub: Press Release – Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2025.

Press Release in respect of Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2025 is enclosed herewith.

Request you to take it on record and disseminate it on your website.

Thanking you.

Yours sincerely,

For Inventurus Knowledge Solutions Limited

Sameer Digitally signed by Sameer Shashikant Shashikant Chavan Date: 2025.07.31 Chavan 22:13:51 +05'30'

Sameer Chavan

Company Secretary and Compliance Officer

Membership No. F7211

Encl: As above

==> picture [141 x 53] intentionally omitted <==

PRESS RELEASE

IKS Health Reports Robust Q1 FY26 Results with 16% Year-over-Year Revenue Growth and 59%

Year-over-Year PAT Increase

• Revenue growth in Q1 16% YoY in INR, 13% YoY in USD

• Q1 EBITDA up 36% YoY; 5% QoQ

• PAT up 59% YoY; 3% QoQ

India | July 31, 2025: Inventurus Knowledge Solutions Limited (NSE: IKS), a technology-enabled healthcare solutions provider, today announced strong growth in Q1 FY26. IKS Health, a care enablement platform focused on supporting physician enterprises primarily in the US, reported its financial results for the quarter ended June 30, 2025.

“Our performance this quarter reflects the continued momentum in our business and the stickiness of our integrated tech-led care enablement platform built on strong client relationships, scalable solutions, and disciplined execution,” said Sachin K. Gupta, Founder & Global CEO, IKS Health. “The sustained revenue growth at 16% and improvement of EBITDA margin for the combined entity to 32% demonstrates the impact of our technology-led care enablement platform and global delivery capabilities. As we move forward, our focus remains on deepening client value, investing in innovation, and scaling our platform to address the evolving needs of the healthcare ecosystem.”

Nithya Balasubramanian, CFO, IKS Health said, “We delivered a strong financial performance in Q1 FY26, driven by consistent revenue growth and continued focus on operational efficiency. Our EBITDA margin improvement reflects disciplined cost management, scalability of our platform, and prudent capital allocation. As we move ahead, we remain committed to sustaining healthy margins while strategically investing in capabilities that drive long-term value creation.”

Key Financial Highlights: Q1FY26 ended on June 30, 2025

• Revenue at ₹7,401 million (15.6% YoY / + 2.2% QoQ growth)

• EBITDA at ₹2,378 million at 32.1% of revenue (36.3% YoY / +5.1% QoQ growth)

• PAT at ₹1,515 million at 20.5% of revenue (58.7% YoY / 2.5% QoQ growth)

• Adjusted PAT at ₹1,682 million at 22.7% of revenue (51.4% YoY / 2.2% QoQ growth)

==> picture [141 x 53] intentionally omitted <==

Business Highlights:

IKS Health continues to expand its reach and impact through strategic partnerships. The following highlights key collaborations, including both new alliances and the expansion of existing relationships, that demonstrate the company's commitment to driving financial outcomes, enabling growth, and enhancing clinical efficiencies for healthcare providers.

• Mission Community Hospital: New partnership to drive financial outcomes and accountability with end-to-end revenue cycle across the hospital acute care and ambulatory surgery spaces

• Bicycle Health: New partnership leveraging IKS to manage revenue cycle, enabling rapid growth and scale of the virtual network

• OrthoNY: Expanded partnership to introduce IKS Virtual Clinical Assistant at a growing specialty network to take on administrative tasks and support clinical efficiencies in addition to existing RCM services.

• A top 5 Health System: Expanded partnership for coding to drive revenue performance and mitigate operational inefficiencies.

Recognition & Awards

• IKS Health received the below notable recognitions:

• ET HRWorld Exceptional Employee Experience – Large Scale Award

• BW CFO Finance & Strategy Excellence Awards

  • Excellence in Mergers and Acquisitions Award - Gold (Organizational Category)

  • Best Woman CFO, Nithya Balasubramanian (Individual Category)

Safe Harbour

Certain statements in this release concerning our future growth prospects may be seen as forward-looking statements, which involve a number of risks and uncertainties that could cause the actuals to differ materially from such statements. It is not possible to undertake to update any such statement that may have been made from time to time.

—---------------------------------------------------------------------------------------------------------------------

==> picture [141 x 53] intentionally omitted <==

About IKS Health

IKS Health takes on the chores of healthcare—spanning administrative, clinical, and operational burdens—so that clinicians can focus on their core purpose: delivering great care. Combining pragmatic technology and dedicated experts, IKS enables stronger, financially sustainable enterprises. IKS’s Care Enablement Platform delivers data-driven value and expertise across the care journey, and IKS is a partner for clinician enterprises looking to effectively scale, improve quality, and achieve cost savings through forward-thinking solutions. Founded in 2006, IKS’s global workforce supports large health systems across the United States. For more information, visit ikshealth.com.

Inventurus Knowledge Solutions Limited was listed on National Stock Exchange of India Limited (NSE) and BSE Limited (Bombay Stock Exchange) on December 19, 2024. {Scrip codes: NSE - IKS and BSE - 544309}

MEDIA CONTACT - IKS HEALTH	INVESTOR RELATIONS CONTACT - IKS HEALTH
Srushti Rao	Saransh Mundra
Vice President - Communications	Head - Investor Relations
srushti.rao@ikshealth.com	investor_relations@ikshealth.com

-xx-xx-xx-